Greystone Associates                                                                                                           The Power of Insight   
Home About Greystone News Events Contact
 Drug Delivery: Nanoparticle Drug Delivery

Buy This Research

$1,975

 ¤ Buy Now

  Resources   Report
 Nanoparticle Drug Delivery: Technologies, Targets and Therapeutics
 

Advances in nanotechnology that enable drugs to be delivered in ways that preserve their efficacy and to precise therapeutic targets are creating a host of opportunities for drug developers. A variety of nanostructures are being investigated as functional drug carriers for a wide range of therapies, most notably cardiovascular medicine, autoimmune diseases, and cancer. While the concept of nanoparticles in drug delivery is not new, the number of research programs and active drug development projects has escalated as funding to nanotechnology developers has increased. The result is the emergence of a host of novel nanotechnologies tailored to meet the physicochemical requirements of drug developers. Nanoparticles have already improved the availability and efficacy of some drugs, and the capabilities that evolving technologies possess will leads to a dramatic increase in the number of therapies delivered via nanoparticles.

Publication Date: May 2008

Table of Contents

 

Executive Summary

 

Engineered Drug Delivery Market Overview

 

Market Dynamics

Competitive Landscape

Demand Drivers

Factors Limiting Growth

 

Nanoparticle Design & Technology Factors

 

Drug Solubility

Dosage Forms

Pharmacokinetics

Bioavailability

 

Commercial Nanoparticle Platform Assessment

 

Mucoadhesive Nanospheres

Composite Nanoshells

Magnetic Nanoparticles

Quantum Dots

Optical Activation

Emerging Nanoparticle Delivery Technologies

 

Nanoparticle Drug Delivery Market Drivers

 

Safety

Targeted Drug Delivery

Funding Programs

Patient/Consumer Sentiment

Enhanced Compliance

 

Near-term Nanoparticle Delivery Therapeutics

 

Autoimmune Diseases

Cardiovascular Medicine

Cancer Therapy

Musculoskeletal

Vaccines

Emerging Markets

Existing/Approved Drugs

New Drug Discovery

DNA-based Therapies

 

Market Factors

 

Government Regulations

Health Standards Organizations

Growth of Self-Administration

Managed Care Initiatives

Shifting Patient Demographics

Patent Expiry and Generics

Rx-to-OTC Switching

 

Nanoparticle Drug Delivery - Company Profiles

 

About Our Reports

Our reports are carefully researched and written to provide timely and insightful analysis of key factors and developments shaping the commercial marketplace. The focused nature of our publications is designed to allow readers to identify emerging demand and growth opportunities in selected markets. Numerous charts, tables and graphs complement the text, with evaluations and assessments of current and probable future market developments, technology issues and business factors - information necessary to compete effectively in the global marketplace.